Contralateral Prophylactic Mastectomy (CPM) American Society of Breast Surgeon Guidelines

  • Current consensus guidelines from the American Society of Breast Surgeons:
    • Do not recommend CPM for women with sporadic breast cancers
  • A Cochrane review of 8 studies evaluating patients who underwent CPM:
    • Concluded that while CPM reduces risk of contralateral breast cancer:
      • It is not associated with improved survival
  • Reasons for not recommending CPM include:
    • A low estimated risk of cancer in the contralateral breast (2% to 6% over 10 years)
    • Increased complication rates
    • Studies showing that CPM does not improve survival or recurrence from the index cancer
  • References:
    • Lostumbo L, Carbine N, Wallace J, Ko H. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2004(4):CD002748.
    • Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the american society of breast surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106-3111

Leave a comment